Layla, a one-year-old girl with leukemia, is in remission thanks to gene-editing technology that allowed her to receive modified immune cells from another person.
Her case represents the second trial of gene-editing as a therapy — the first was carried out last year in patients with HIV. More similar trials are planned — and companies are also preparing to trial therapies that inject DNA that codes for gene-editing enzymes directly into the human body.
Leukemia success heralds wave of gene-editing therapies.
Read more about it here http://www.nature.com/news/leukaemia-success-heralds-wave-of-gene-editing-therapies-1.18737